Publications

(2020). Pandemic pandemonium: pausing clinical research during the COVID-19 outbreak. *Circulation 2020 (Epub Ahead of Print).

HTML

(2020). Angiotensin receptor blockers and the risk of cancer: insights from clinical trials and recent drug recalls. Current Hypertension Reports, 22(20).

HTML

(2019). Medicare reimbursement policy for ambulatory blood pressure monitoring: a qualitative analysis of public comments to the Centers for Medicare and Medicaid Services. Journal of Clinical Hypertension.

PDF HTML

(2019). Current status of angiotensin receptor blocker recalls. Hypertension.

PDF HTML

(2019). Privacy-preserving generative deep neural networks support clinical data sharing. Circulation: Cardiovascular Quality and Outcomes, 12(7).

PDF Supplement HTML

(2019). Hypertension. Annals of Internal Medicine, 170(9).

HTML

(2019). Hypertension hot potato — anatomy of the angiotensin-receptor blocker recalls. New England Journal of Medicine, 380(17).

HTML Audio Interview

(2019). Score one for the clinical trial data sharing experiment. European Journal of Preventive Cardiology, 26(6).

PDF HTML

(2019). For what factors should we normalize urinary extracellular mRNA biomarkers?. Biomolecular Detection and Quantification (17) March.

PDF HTML

(2019). Strengthening a societal tie and other new initiatives for 2019. Journal of Human Hypertension, 33(3).

PDF HTML

(2019). Personalized medicine and the treatment of hypertension. Current Hypertension Reports, 21(2).

HTML

(2019). Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism. Journal of Clinical Endocrinology & Metabolism, 104(2).

HTML

(2018). Privacy-preserving generative deep neural networks support clinical data sharing.

bioRxiv PDF bioRxiv HTML

(2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018), a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 7(1).

PDF HTML

(2018). Out-of-office blood pressure monitoring in 2018. JAMA, 320(17).

HTML

(2018). Monitoring blood pressure outside of the doctor's office. JAMA, 320(17).

HTML

(2018). Clinical research using extracellular vesicles, insights from the International Society for Extracellular Vesicles 2018 Annual Meeting. Journal of Extracellular Vesicles, 7(1).

PDF HTML

(2018). Human urinary mRNA as a biomarker of cardiovascular disease. Circulation: Genomic and Precision Medicine, 11(9).

PDF Supplement HTML Video summary Podcast interview

(2018). Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. European Heart Journal, 39(33).

PDF Supplement HTML

(2018). Primary aldosteronism. Circulation, 138(8).

PDF HTML

(2018). Opening opportunities with open data. JACC: Heart Failure, 6(6).

PDF HTML

(2018). Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. Journal of Extracellular Vesicles, 7(1).

PDF HTML

(2018). Countries’ geographic latitude and their human populations’ cholesterol and blood pressure.

bioRxiv PDF bioRxiv HTML

(2018). Pharmacologic treatment of hypertension. Nephrology Secrets, 4th ed, Elsevier.

HTML (Chapter) HTML (Book)

(2018). Use of physician-recommended non-pharmacological strategies for hypertension control among hypertensive patients. Journal of Clinical Hypertension, 20(3).

PDF HTML Commentary on this work

(2017). Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clinical Endocrinology (Oxf), 87(6).

PDF HTML

(2017). Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. Journal of Allergy and Clinical Immunology, 140(1).

PDF HTML

(2017). Data-sharing models. New England Journal of Medicine, 376(23).

HTML

(2017). Reach Out Churches, a community-based participatory research pilot trial to assess the feasibility of a mobile health technology intervention to reduce blood pressure among African Americans. Health Promotion Practice, 19(4).

HTML

(2017). Cigarette smoking and subtypes of uncontrolled blood pressure among diagnosed hypertensive patients: paradoxical associations and implications. American Journal of Hypertension, 30(6).

PDF Supplement HTML Commentary about this work

(2017). Hypertension: from pre-hypertension to heart failure. Cardiology Clinics, 35(2).

PDF HTML

(2017). Alternative approaches for lowering blood pressure. Hypertension: A Companion to Braunwald’s Heart Disease, 3rd ed, Elsevier.

HTML (Chapter) HTML (Book)

(2017). EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nature Methods, 14(3).

HTML Supplemental Text and Figures Supplemental Table

(2016). Primary aldosteronism in the primary care clinic: rife or rare?. Endocrine Practice, 22(11).

HTML

(2016). Personalized medicine and treatment approaches in hypertension: current perspectives. Integrated Blood Pressure Control, 2016(9).

PDF HTML Video intro to paper

(2016). Acute increase in blood pressure during inhalation of coarse particulate matter air pollution from an urban location. Journal of the American Society of Hypertension, 10(2).

HTML

(2016). Hypertension section (within Cardiovascular medicine chapter). In: Textbook of Family Medicine, 9th ed. Philadelphia: Elsevier Saunders.

HTML (Book)

(2015). Serum cortisol-to-cortisone ratio and blood pressure in severe obesity before and after weight loss. CardioRenal Medicine, 6(1).

PDF HTML

(2015). Aldosterone synthase promoter polymorphism and cardiovascular phenotypes in a large, multiethnic population-based study. Journal of Investigative Medicine, 63(7).

PDF HTML

(2015). Resistance to recommending exercise in hypertension?. Journal of Human Hypertension, 29(6).

PDF

(2014). Anxiety in the "age of hypertension". Current Hypertension Reports, 16(10).

HTML

(2014). Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: insights from the Veterans Affairs CART Program. American Heart Journal, 168(3).

HTML

(2014). A controlled trial of renal denervation for resistant hypertension. New England Journal of Medicine, 370(15).

HTML

(2014). The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension. Current Hypertension Reports, 16(3).

HTML

(2014). Arm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelines. Journal of Clinical Hypertension, 16(3).

PDF HTML

(2014). A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension. Journal of Human Hypertension, 28(1).

PDF HTML

(2013). Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema. Journal of Allergy and Clinical Immunology: In Practice, 1(5).

PDF HTML

(2013). Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenetics and Genomics, 23(9).

PDF HTML

(2013). Data quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: the VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program. American Heart Journal, 165(3).

HTML

(2012). Detection and recognition of hypertension in anxious and depressed patients. Journal of Hypertension, 30(12).

HTML

(2011). The possibility of unmeasured confounding variables in observational studies: a forgotten fact?. Heart, 97(22).

HTML

(2011). Combination therapy as initial treatment for newly diagnosed hypertension. American Heart Journal, 162(2).

PDF HTML

(2011). Pericardial effusion in renal disease: to tap or not to tap. Cardiology, 120(4).

HTML

(2010). Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy, 65(11).

PDF HTML

(2010). Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenetics and Genomics, 20(9).

PDF HTML

(2008). Les effets secondaires aigus des inhibiteurs de l’enzyme de conversion de l’angiotensine dont l’angioœdème, différents dans leur étiologie clinique, partagent une physiopathologie semblable. Revue Française d’Allergologie et d’Immunologie Clinique, 48(6).

HTML

(2008). Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension, 51(2).

PDF HTML

(2008). Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension, 51(1).

PDF HTML Commentary about this work

(2007). Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema. Journal of Allergy and Clinical Immunology, 120(2).

HTML

(2006). Angiotensin-converting enzyme inhibitor-associated angioedema. Immunology and Allergy Clinics of North America, 26(4).

HTML

(0001). .